QDEL QuidelOrtho Corporation
QuidelOrtho Corporation (QDEL) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is $0.18 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +12.9% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About QuidelOrtho Corporation
Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe.
Sector
Healthcare
Industry
Diagnostic Substances